DAB389-IL-4

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameDAB389-IL-4
Drug Alias NameIL-4 fusion toxin (Seragen)interleukin-4 fusion toxin (Ligand)IL-4 fusion toxin (Seragen/Ligand)interleukin-4 fusion toxin (Seragen/Ligand)IL-4 fusion toxin (Ligand) +[7] 
ClassificationBiologics > Protein drugs > ToxinBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-4 receptors stimulants
TargetsInterleukin-4 receptors
Therapy Area/IndicationsRejection of organ transplantationHypersensitivityAutoimmune Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSeragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSeragen IncLigand Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationHypersensitivityAutoimmune Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A